Why the study?
The study aimed to compare outcomes between endovascular treatment and femoropopliteal artery bypass in patients with TASC II type C femoropopliteal lesions.
Key points are not available for this paper at this time.
Population
Patients with TASC II type C femoropopliteal lesions
Comparison
Endovascular treatment vs femoropopliteal artery bypass
ET may reduce hospitalization and costs with similar patency in TASC C lesions; leaves open need for randomized trials.
Objectives: In this study, we aimed to compare the outcomes of endovascular treatment (ET) and femoropopliteal artery bypass (FPB) in patients with Trans-Atlantic Inter-Society Consensus (TASC) II type C femoropopliteal lesions.
No takes yet. Share an insight, caveat, or question.
Onur Saydam (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: